- Home
- HRTX vs MIO Comparison
HRTX vs MIO Comparison
Compare HRTX & MIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRTX
- MIO
- Stock Information
- Founded
- HRTX 1983
- MIO 2021
- Country
- HRTX United States
- MIO United States
- Employees
- HRTX N/A
- MIO N/A
- Industry
- HRTX Biotechnology: Pharmaceutical Preparations
- MIO Investment Managers
- Sector
- HRTX Health Care
- MIO Finance
- Exchange
- HRTX Nasdaq
- MIO Nasdaq
- Market Cap
- HRTX 229.7M
- MIO 207.7M
- IPO Year
- HRTX 1987
- MIO N/A
- Fundamental
- Price
- HRTX $1.63
- MIO $11.93
- Analyst Decision
- HRTX Strong Buy
- MIO
- Analyst Count
- HRTX 3
- MIO 0
- Target Price
- HRTX $5.67
- MIO N/A
- AVG Volume (30 Days)
- HRTX 1.6M
- MIO 46.0K
- Earning Date
- HRTX 03-11-2025
- MIO 01-01-0001
- Dividend Yield
- HRTX N/A
- MIO 4.57%
- EPS Growth
- HRTX N/A
- MIO N/A
- EPS
- HRTX N/A
- MIO N/A
- Revenue
- HRTX $137,737,000.00
- MIO N/A
- Revenue This Year
- HRTX $13.10
- MIO N/A
- Revenue Next Year
- HRTX $18.76
- MIO N/A
- P/E Ratio
- HRTX N/A
- MIO N/A
- Revenue Growth
- HRTX 12.13
- MIO N/A
- 52 Week Low
- HRTX $1.04
- MIO $9.18
- 52 Week High
- HRTX $3.93
- MIO $11.36
- Technical
- Relative Strength Index (RSI)
- HRTX 54.36
- MIO 44.97
- Support Level
- HRTX $1.46
- MIO $11.83
- Resistance Level
- HRTX $1.71
- MIO $12.05
- Average True Range (ATR)
- HRTX 0.09
- MIO 0.14
- MACD
- HRTX 0.00
- MIO 0.00
- Stochastic Oscillator
- HRTX 48.65
- MIO 47.22
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
About MIO Pioneer Municipal High Income Opportunities Fund Inc.
Pioneer Municipal High Income Opportunities Fund Inc. is a diversified, closed-end management investment company. The Fund's primary investment objective is to provide holders of the Fund's common stock with a high level of current income exempt from regular federal income tax.